this study investigated whether in vitro immunotherapy with ril-2 which augments human natural cytotoxicity and generation of lymphokine-activated killer cells diminished or inhibits the severity of therapeutically induced human in vitro nk immunosuppression .
C1335621
ril
C0086418
human